Istituto Oncologico Veneto

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Simona Agata

Simona Agata

Person: Academic

20012018
No photo of Valentina Agnusdei

Valentina Agnusdei

Person: Academic

20162018
No photo of Elisa Alducci

Elisa Alducci

Person: Academic

20112018

Projects 2018 2018

I. O. V. - NUOVI MODELLI ORGANIZZATIVI: PDTA E INDICATORI

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

I. O. V. - ONCOLOGIA SPERIMENTALE

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

I. O. V. - GENOMICA ONCOLOGICA E BIG DATA

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Research Output 1974 2019

18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases

Cuppari, L., Reccia, P., Burei, M., Cervino, A. R. & Evangelista, L., Feb 2019, In : Clinical Nuclear Medicine. 44, 2, p. e96-e97

Research output: Contribution to journal › Article

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 othersRutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 1 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journal › Article

Multicenter Studies
Melanoma
Safety
Mutation
PLX4032

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 othersRutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journal › Article